ALSO NOTED: Ex-Chinese drug official gets 15 years;Sun gets FDA nod for generic dementia drug;

> A former Chinese drug regulator has been sentenced to 15 years in prison for bribery and embezzlement; the harsh punishment is seen as an example of the country's crackdown on food and drug safety. Report

> India's Sun Pharma got the FDA's blessing for its generic version of Exelon, an Alzheimer's and Parkinson's remedy made by Novartis--but won't launch the drug immediately because of outstanding patent litigation. Report

> GlaxoSmithKline has sold 2 million starter kits of its Alli weight-loss product in the five months since it was introduced; the results were in line with company expectations. Report

> A group of researchers are focused on developing a new, nonhormonal contraceptive that uses RNAi technology to silence the ZP3 gene, which is required to fertilize an egg during ovulation. Report

> A molecular mechanism at work during periods of stress may shed light on developing new therapies for post-traumatic stress disorder and other conditions. Report

And Finally... Americans love their sleeping pills, paying $4.5 billion for them annually. But patients think they work better than they really do. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.